Andorra vs Singapore: Hib vaccine
Andorra
97
in 2025
Singapore
97
in 2025
Andorra rank
32nd
Singapore rank
32nd
Hib vaccine over time
- Andorra
- Singapore
How they compare
Andorra currently reports 97 against 97 in Singapore, a difference of 0.
The two have swapped places 3 times across 13 shared years of data; in 2013 it was Andorra ahead.
Andorra ranks 32nd and Singapore ranks 32nd of 193 countries.
Andorra has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.71 | 93.14 | 4.57 | Andorra |
| 2020s | 97.5 | 97.5 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hib vaccine, Andorra or Singapore?
- Andorra, at 97 against 97 in Singapore as of 2025.
- What is the difference in hib vaccine between Andorra and Singapore?
- 0, with Andorra ahead.
- How many years of comparable data are there for Andorra and Singapore?
- 13 years are reported by both, from 2013 to 2025.
- How do Andorra and Singapore rank globally for hib vaccine?
- Andorra ranks 32nd and Singapore ranks 32nd of 193 countries.
- Where does this data come from?
- Our World in Data, published as Hib vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.